Feb 25 (Reuters) - Corbion NV CORB.AS :
* FY OPERATING RESULT EUR 82.0 MILLION VERSUS EUR 104.1
MILLION
YEAR AGO (CORRECTS METRIC)
* FY SALES 1.071 BILLION EUR VERSUS 986.5 MILLION EUR YEAR
AGO
* FY TOTAL NET SALES WAS EUR 1,070.8 MILLION (FY 2020: EUR
986.5
MILLION)
* FY NET SALES ORGANIC GROWTH WAS 14.7%. CORE NET SALES
ORGANIC
GROWTH: 15.0%
* FY ADJUSTED EBITDA WAS EUR 135.8 MILLION (FY 2020: EUR
158.8
MILLION; ORGANIC DECREASE: 7.6%)
* FY FREE CASH FLOW WAS EUR -97.0 MILLION (FY 2020: EUR 32.1
MILLION)
* END-FY COVENANT NET DEBT/COVENANT EBITDA AT YEAR-END WAS
2.6X
(YEAR-END 2020: 1.7X)
* FY NET SALES EUR 1,070.8 MILLION VERSUS EUR 986.5 MILLION
YEAR
AGO
* FY ADJUSTED EBITDA EUR 135.8 MILLION VERSUS EUR 158.8
MILLION
YEAR AGO
* OUTLOOK 2022: IN INCUBATOR WE EXPECT TO REACH EBITDA
BREAK-EVEN
IN THE ALGAPRIME DHA BUSINESS DRIVEN BY SIGNIFICANT SALES GROWTH
(ADDS PERIOD)
* OUTLOOK 2022: FOR INCUBATOR AS A WHOLE, WE EXPECT EBITDA
INVESTMENT AT APPROXIMATELY -1% OF CORBION CORE SALES, IN-LINE
WITH OUR ADVANCE 2025 STRATEGY (ADDS PERIOD)
* OUTLOOK 2022: IN LACTIC ACID & SPECIALTIES THE PLA JOINT
VENTURE WITH TOTALENERGIES IS DRAWING INCREASED VOLUMES OF
LACTIC ACID WHILE THE DERIVATIVES ARE EXPECTED TO CONTINUE TO
PERFORM WELL (ADDS PERIOD)
* OUTLOOK 2022: IN SUSTAINABLE FOOD SOLUTIONS WE EXPECT TO
GROW
VOLUMES IN LINE WITH MARKET GROWTH, FOLLOWING SIGNIFICANT
MARKET SHARE GAINS WE MADE OVER THE PAST TWO YEARS (ADDS PERIOD)
* PROPOSAL TO DISTRIBUTE UNCHANGED, REGULAR DIVIDEND IN CASH
OF €
0.56 PER ORDINARY SHARE TO BE SUBMITTED FOR APPROVAL TO ANNUAL
GENERAL MEETING OF SHAREHOLDERS
Source text for Eikon: ID:nL8N2V01CB
Further company coverage: CORB.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))